ACAD Operating Expenses

Acadia Pharmaceuticals Inc · Operating Expenses

ACAD logo

ACAD Operating Expenses

Latest reported$951.30M
ACAD TTM Operating Expenses (-$12.66M → $951.30M)
High-resolution chart · PNG

ACAD operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Acadia Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
951,297,000
920,948,000
877,696,000
721,619,000
700,289,000
682,127,000
645,162,000
739,072,000
794,025,000
755,468,000
758,177,000
760,111,000
664,702,000
675,510,000
730,665,000
723,379,000
704,166,000
692,343,000
635,443,000
645,457,000
706,901,000
701,816,000
707,791,000
674,314,000
607,957,000
594,619,000
566,023,000
539,086,000
517,969,000
498,732,000
452,921,000
440,335,000
424,810,000
404,449,000
405,401,000
383,414,000
361,085,000
336,628,000
285,740,000
243,441,000
206,131,000
174,383,000
164,673,000
147,693,000
133,665,000
115,918,000
93,350,000
76,949,000
62,991,000
50,848,000
39,441,000
34,439,000
29,273,000
25,693,000
25,793,000
24,496,000
24,288,000
25,304,000
24,919,000
25,292,000
26,158,000
25,707,000
27,040,000
31,240,000
35,906,000
43,954,000
51,867,000
55,928,000
61,090,000
65,669,000
69,374,000
75,126,000
78,605,000
74,043,000
70,209,000
65,244,000
59,876,000
59,963,000
57,187,000
55,006,900
57,010,900
51,274,200
46,762,600
42,158,500
33,576,300
31,469,000
30,699,500
1,042,300
-6,861,500
-9,438,900
-12,664,100
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.